SPIA
ANVS icon

Steward Partners Investment Advisory’s Annovis Bio ANVS Stock Holding History

Steward Partners Investment Advisory’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,000
Closed -$2.07K – 4314
2025
Q3 		$2.07K Hold
1,000
– – ﹤0.01% 3914
2025
Q2 		$2.17K Hold
1,000
– – ﹤0.01% 3710
2025
Q1 		$1.5K Buy
+1,000
New +$3.06K ﹤0.01% 3699

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Steward Partners Investment Advisory's ANVS Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of Annovis Bio (ANVS) in Q4 2025, closing a stake of 1,000 shares — an estimated $2.07K sold.

Steward Partners Investment Advisory first reported a position in ANVS in Q1 2025 and held it in 3 quarters. The position peaked at $2.17K in Q2 2025. 53 funds tracked by Wall St. Rank hold ANVS as of Q4 2025.

  • Steward Partners Investment Advisory reported no remaining Annovis Bio position as of Q4 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,000 Annovis Bio shares in Q4 2025, an estimated $2.07K.
  • Steward Partners Investment Advisory first reported a position in Annovis Bio in Q1 2025 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Annovis Bio position peaked at $2.17K in Q2 2025.
  • 53 funds tracked by Wall St. Rank held Annovis Bio as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.